Surescripts, LLC

Surescripts, based in the US, delivers essential health intelligence solutions that enhance communication and data sharing within the healthcare ecosystem, thereby improving clinical decision-making and medication management. Founded in 2002, Surescripts, LLC is a healthcare technology company headquartered in Arlington, US, that focuses on integrating health information systems to streamline prescription and authorization processes. The company has undergone significant development since its inception, consistently evolving to meet the needs of the healthcare sector. The current CEO is Tom Skelton, who leads the company amid its ongoing strategic initiatives to optimize health information exchange.

In October 2024, Surescripts was targeted for acquisition by TPG, marking an important deal in its operational journey. Surescripts primarily offers a suite of health intelligence solutions designed to streamline communication and data sharing across the healthcare ecosystem. Their core products include Intelligent Prescribing, Intelligent Prior Authorization, Benefit & Price Intelligence, and Interoperability tools that enhance clinical decision-making and improve medication management. These solutions function by integrating critical patient information directly into healthcare providers' workflows, thereby reducing errors, ensuring clearer communication, and facilitating timely access to necessary treatments.

The company serves a diverse client base that includes healthcare providers, health systems, pharmacy benefit managers (PBMs), and life sciences companies across the United States, aiming to improve patient safety, reduce costs, and enhance the quality of care. Surescripts' products specifically address challenges in prescription management and prior authorization processes, empowering clinicians to make informed decisions at the point of care. Surescripts generates revenue through a combination of subscription-based models and transactional fees associated with its health information network services. Clients typically engage with Surescripts on a subscription basis, paying for access to a suite of tools aimed at improving interoperability and clinical workflows.

Transactions occur as clients utilize services such as Electronic Benefit Verification and Electronic Prescribing for Controlled Substances, charging based on usage or volume of transactions processed through the network. The company’s pricing structure accommodates various healthcare stakeholders, including large health systems and individual pharmacies, reflecting the specific services utilized, such as Intelligent Prior Authorization and Benefit & Price Intelligence, ultimately facilitating a more efficient care experience for end-users. In October 2024, TPG agreed to acquire a majority stake in Surescripts, LLC, with financial terms undisclosed. This acquisition is aimed at enabling Surescripts to accelerate innovation in its healthcare system technology and continuously meet the evolving needs of clinicians and patients.

Future growth strategies include developing and launching new products designed to enhance healthcare workflows, while also expanding into new markets and geographic regions, with specific targets to be defined as the integration with TPG progresses.